Supernus surges 20.7% premarket on all-stock merger with Indivior

M&A · PartnershipCorporate Action
โดย Investing.com·Read original
Summary · why it matters

Supernus Pharmaceuticals surged 20.7% in premarket trading after agreeing to an all-stock merger of equals with Indivior Pharmaceuticals. Under the deal, Supernus shareholders will receive 1.5401 Indivior shares for each share held, while Indivior shareholders will receive a one billion dollar special cash dividend before closing. The combined company will retain the Supernus name and continue trading under the SUPN ticker. Other notable movers included GameStop, which slipped six percent after announcing a debt-for-equity swap that will exchange approximately 1.4 billion dollars of convertible debt for newly issued Class A common stock, and Ferguson, which climbed 7.1 percent ahead of its inclusion in the S&P 500 on August fifth.

Impact on stocks 5

Biotech & Genomic Medicine▲ · 1 stocks
Consumer Discretionary▼ · 1 stocks
GameStop Corp.
GME
▼ NegativeCapitalrelevance

Debt-for-equity swap exchanging convertible debt for common stock dilutes shareholders

Climate Adaptation & Water▲ · 1 stocks
Ferguson Plc
FERG
▲ PositiveCapitalrelevance

Inclusion in S&P 500 on August fifth is a positive index event

Electrification & Mobility▲ · 1 stocks
Industrials▲ · 1 stocks
© 2026 MarketDXNews